The Australian Institute of Policy and Science has announced the 2015 Victorian Young Tall Poppy Science Awards, celebrating the best and brightest young achievers in the state. [ + ]

Rose Hiscock has been announced as the inaugural director of Science Gallery Melbourne, a venue for science and art collaboration planned for the heart of Melbourne's new innovation precinct. [ + ]

Invion has opened a share purchase plan (SPP), allowing eligible shareholders to purchase up to $15,000 worth of shares at a discount and without any brokerage or transaction costs. [ + ]

Minister for Health Sussan Ley has announced $630 million to support Australia's researchers in their search to find the next prevention of disease or cure. [ + ]

The ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP) has officially launched its new research node at Macquarie University. [ + ]

Drug development company Armaron Bio has begun its Phase II clinical trial for NP202, its lead candidate drug for heart failure. [ + ]

Trajan Scientific and Medical has welcomed Prime Minister Malcolm Turnbull to its global headquarters in Melbourne, in a visit which showcased how the company's partnerships with academia and start-ups are demonstrative of the Prime Minister's vision for an innovation agenda. [ + ]

Scientists from QUT, who are studying the use of plants to combat golden staph infections, heal wounds and treat diseases, have received an extra $1 million in funding. [ + ]

A new clinical trial will evaluate the combination of Viralytics' investigational cancer immunotherapy, CAVATAK, with MSD's KEYTRUDA, an anti-PD-1 (programmed death receptor-1) therapy. [ + ]

A cooperation arrangement signed in Brussels will provide Australia with access to what is said to be the most comprehensive Earth observation program in world history. [ + ]

University of Sydney researchers have identified and mapped the genetic traits that will improve the accuracy of breeding high-performing working dogs for Australian farmers. [ + ]

Merck's healthcare business has entered into a three-year collaboration to validate new therapeutic concepts in the field of oncology with drug discovery company Selvita, headquartered in Poland. [ + ]

The Australian Academy of Science has announced $190,000 to help the survival of some of Australia's endangered species, help prevent hospital readmissions in central Australia, model climate change adaptation and support international travel and scientific conferences. [ + ]

Researchers have identified the key protein involved in driving the progression of multiple sclerosis (MS) and other autoimmune diseases through the body's 'super-inflammatory' immune response. [ + ]

Physicists have discovered a phase that is characterised by an unusual ordering of electrons. It is said that the phase could hold the solution to a longstanding mystery in condensed matter physics. [ + ]